Prescott G. Woodruff spends much of his time researching Asthma, Immunology, COPD, Physical therapy and Inflammation. Prescott G. Woodruff has researched Asthma in several fields, including Lebrikizumab, Cohort study, Eosinophilia, Bronchial hyperresponsiveness and Microarray. His study in the field of Interleukin 13 also crosses realms of Periostin.
His COPD research integrates issues from Pulmonary disease, Prospective cohort study, Spirometry and Lung. His Physical therapy study combines topics in areas such as Internal medicine, Interquartile range, Cohort and Confidence interval. His work deals with themes such as Microbiome, Reslizumab, Allergy and Goblet cell, which intersect with Inflammation.
Prescott G. Woodruff mainly focuses on Immunology, Internal medicine, COPD, Asthma and Inflammation. His Immunology research is multidisciplinary, relying on both Sputum, Gene expression and Disease. In his study, Prospective cohort study is inextricably linked to Physical therapy, which falls within the broad field of Internal medicine.
His research integrates issues of Pulmonary disease, Exacerbation, FEV1/FVC ratio, Lung and Spirometry in his study of COPD. His Asthma course of study focuses on Confidence interval and Respiratory disease. As part of his studies on Inflammation, he often connects relevant areas like Biomarker.
Internal medicine, COPD, Immunology, Asthma and Cohort are his primary areas of study. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Cardiology. His research in COPD intersects with topics in Pulmonary disease, Exacerbation, FEV1/FVC ratio, Lung and Spirometry.
His research integrates issues of Gene expression and Disease in his study of Immunology. His work in Asthma addresses issues such as Airway, which are connected to fields such as Lebrikizumab. His Inflammation research integrates issues from ARDS and Dexamethasone.
Prescott G. Woodruff mainly investigates Internal medicine, COPD, Asthma, Immunology and Spirometry. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Tuberculosis. His COPD research is multidisciplinary, incorporating perspectives in Odds ratio, Pulmonary disease, Exacerbation, Chronic bronchitis and Rate ratio.
Prescott G. Woodruff interconnects Off Treatment, Sputum, Rheumatoid arthritis, Asthma Control Questionnaire and Airway in the investigation of issues within Asthma. In general Immunology, his work in Immune system, Inflammation and Antibody is often linked to Coronavirus linking many areas of study. The study incorporates disciplines such as Cardiology, Lung volumes, FEV1/FVC ratio, Depression and Lung disease in addition to Spirometry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Prescott G. Woodruff;Barmak Modrek;David F. Choy;Guiquan Jia.
American Journal of Respiratory and Critical Care Medicine (2009)
Azithromycin for Prevention of Exacerbations of COPD
Richard K. Albert;Richard K. Albert;John Connett;William C. Bailey;Richard Casaburi.
The New England Journal of Medicine (2011)
Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids
Prescott G. Woodruff;Homer A. Boushey;Gregory M. Dolganov;Chris S. Barker.
Proceedings of the National Academy of Sciences of the United States of America (2007)
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.
Guiquan Jia;Richard W. Erickson;David F. Choy;Sofia Mosesova.
The Journal of Allergy and Clinical Immunology (2012)
Muc5b is required for airway defence
Michelle G. Roy;Alessandra Livraghi-Butrico;Ashley A. Fletcher;Melissa M. McElwee.
Nature (2014)
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function
Prescott G. Woodruff;R. Graham Barr;Eugene Bleecker;Stephanie A. Christenson.
The New England Journal of Medicine (2016)
Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression.
Prescott G. Woodruff;Gregory M. Dolganov;Ronald E. Ferrando;Samantha Donnelly.
American Journal of Respiratory and Critical Care Medicine (2004)
Roles of epithelial cell-derived periostin in TGF-β activation, collagen production, and collagen gel elasticity in asthma
Sukhvinder S. Sidhu;Shaopeng Yuan;Anh L. Innes;Sheena Kerr.
Proceedings of the National Academy of Sciences of the United States of America (2010)
COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.
Michael C. Peters;Satria Sajuthi;Peter Deford;Stephanie Christenson.
American Journal of Respiratory and Critical Care Medicine (2020)
Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD
G. J. Criner;John E Connett;S. D. Aaron;R. K. Albert.
The New England Journal of Medicine (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Michigan–Ann Arbor
Cornell University
University of California, San Francisco
University of Alabama at Birmingham
University of Arizona
University of Michigan–Ann Arbor
Columbia University
University of Iowa
University of North Carolina at Chapel Hill
Temple University
University of Paderborn
University of Warwick
University of California, Berkeley
Sichuan University
East China University of Science and Technology
Max Planck Society
University of California, Irvine
The Wistar Institute
University of California, San Francisco
University of Oklahoma
Peking University
University of Leicester
McGill University
Georgetown University
University of California, San Francisco
Johns Hopkins University